Niraparib in Tumors Metastatic to the CNS
Clinical trial NCT04992013 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04992013
- Sponsor
- Massachusetts General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-05
- Primary completion
- 2026-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.